Kurt Brown

Person

Narbeth, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
JAK1 pathway inhibitors for the treatment of vitiligo
- Patent number 11,957,661
- Issue date Apr 16, 2024
- Incyte Corporation
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO
- Publication number 20240358680
- Publication date Oct 31, 2024
- INCYTE CORPORATION
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF ASTHMA
- Publication number 20240307353
- Publication date Sep 19, 2024
- INCYTE CORPORATION
- Kurt Andrew Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF URTICARIA USING JAK INHIBITORS
- Publication number 20240058343
- Publication date Feb 22, 2024
- INCYTE CORPORATION
- Cornelius P. Sailer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF PRURIGO NODULARIS
- Publication number 20220378746
- Publication date Dec 1, 2022
- INCYTE CORPORATION
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO
- Publication number 20220175731
- Publication date Jun 9, 2022
- INCYTE CORPORATION
- Paul Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CROHN'S DISEASE USING LOW DOSES OF LAQUINIMOD
- Publication number 20160331742
- Publication date Nov 17, 2016
- Teva Pharmaceutical Industries, Ltd.
- Kurt A Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION OF HUMAN GROWTH HORMONE AND ALBUMIN FORMULATION AND USES THE...
- Publication number 20140162954
- Publication date Jun 12, 2014
- Teva Pharmaceutical Industries, Ltd.
- Kurt Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

JAK1 pathway inhibitors for the treatment of vitiligo

Patents Applicationslast 30 patents

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF ASTHMA

TREATMENT OF URTICARIA USING JAK INHIBITORS

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF PRURIGO NODULARIS

JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO

TREATMENT OF CROHN'S DISEASE USING LOW DOSES OF LAQUINIMOD

FUSION OF HUMAN GROWTH HORMONE AND ALBUMIN FORMULATION AND USES THE...